{"drugs":["Gentian Violet"],"mono":{"0":{"id":"250880-s-0","title":"Generic Names","mono":"Gentian Violet"},"1":{"id":"250880-s-1","title":"Dosing and Indications","sub":{"0":{"id":"250880-s-1-4","title":"Adult Dosing","mono":"<ul><li>Key Pharmaceuticals removed Genapax(R) October 3, 1990. The data related to Genepax(R) in this monograph are included for informational purposes only.<\/li><li><b>Candidal vulvovaginitis:<\/b> one tampon, containing 5 mg gentian violet, should be inserted vaginally for 3 to 4 hours once or twice daily for 12 days; a tampon may be used overnight in resistant cases<\/li><li><b>Infectious disease; Prophylaxis - Skin cleansing procedure:<\/b> apply to affected area once or twice daily<\/li><\/ul>"},"3":{"id":"250880-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Key Pharmaceuticals removed Genapax(R) October 3, 1990 [2]. The data related to Genepax(R) in this monograph are included for informational purposes only.<\/li><li>Candidal vulvovaginitis<\/li><li>Infectious disease; Prophylaxis - Skin cleansing procedure<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><ul><li>Key Pharmaceuticals removed Genapax(R) October 3, 1990 [2]. The data related to Genepax(R) in this monograph are included for informational purposes only.<\/li><li>Foreign body granuloma of skin<\/li><\/ul>"}}},"3":{"id":"250880-s-3","title":"Contraindications\/Warnings","sub":{"0":{"id":"250880-s-3-9","title":"Contraindications","mono":"<ul><li>hypersensitivity to gentian violet<\/li><li>patients with porphyria<\/li><li>use on ulcerative lesions or open wounds<\/li><\/ul>"},"2":{"id":"250880-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},"3":{"id":"250880-s-3-12","title":"Breast Feeding","mono":"<ul><li>WHO: Compatible with breastfeeding.<\/li><li>Micromedex: Infant risk is minimal.<\/li><\/ul>"}}},"5":{"id":"250880-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Discoloration of skin<br\/>"},"6":{"id":"250880-s-6","title":"Drug Name Info","sub":{"2":{"id":"250880-s-6-19","title":"Class","mono":"Antifungal<br\/>"},"3":{"id":"250880-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"250880-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"250880-s-7","title":"Mechanism Of Action","mono":"Vaginal: Possesses antifungal and anthelmintic activity, as well as bactericidal and bacteriostatic activities against gram-positive bacteria .<br\/>"},"10":{"id":"250880-s-10","title":"Monitoring","mono":"<ul><li>clinical improvement in the signs and symptoms of infection being treated<\/li><li>cultures if deemed necessary<\/li><li>mucosal irritation<\/li><\/ul>"},"11":{"id":"250880-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Topical Solution: 1 %, 2 %<br\/><\/li><li><b>Swan Gentian Violet<\/b><br\/>Topical Solution: 1 %<br\/><\/li><\/ul>"},"13":{"id":"250880-s-13","title":"Clinical Teaching","mono":"<ul><li>Warn patients that permanent pigmentation may occur if drug contacts granulation tissue.<\/li><li>This drug may cause skin or mucous membrane irritation, skin ulceration, or staining of skin.<\/li><\/ul>"}}}